Krystal Biotech (KRYS) Payables (2016 - 2026)
Krystal Biotech's Payables came in at $39.41 million for Q3 2026, up 24.3% from $31.7 million a year earlier and up 10.8% from the prior quarter.
Powered by 
Analysis
Krystal Biotech (KRYS) Payables (2016 - 2026) Analysis & Trends
At the end of FY2025, Krystal Biotech's Payables was $39.75 million, down 32.6% from FY2024.
- Payables carries a five-year compound annual growth rate of 80.0% (FY2020 to FY2025).
- Going back by year, Payables was $58.99 million in FY2024 (+174.2%), $21.51 million in FY2023 (-7.7%), $23.31 million in FY2022 (+43.0%) and $16.3 million in FY2021 (+674.2%).
- The five-year range for quarterly Payables is $16.3 million (Q4 2021) to $58.99 million (Q4 2024).
- Year-over-year, Payables has increased for three consecutive quarters, with growth averaging 15.9% over the last eight quarters.
- The fastest year-over-year change in Payables over five years came in Q4 2021 (growth of 674.2%), and the weakest in Q1 2023 (a decline of 42.1%).
- Business Quant data shows KRYS's Payables at $35.57 million (Q2 2026), $31.2 million (Q1 2026) and $39.75 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.17 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -25.19 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.07 Bn |
| 10 | Krystal Biotech | 9.08 Bn | 5.67 Bn | 119.79 Mn | 39.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 39.41 Mn |
| Jun 30, 2026 | 35.57 Mn |
| Mar 31, 2026 | 31.20 Mn |
| Dec 31, 2025 | 39.75 Mn |
| Sep 30, 2025 | 31.70 Mn |
| Jun 30, 2025 | 26.52 Mn |
| Mar 31, 2025 | 28.05 Mn |
| Dec 31, 2024 | 58.99 Mn |
| Sep 30, 2024 | 53.11 Mn |
| Jun 30, 2024 | 43.33 Mn |
| Mar 31, 2024 | 29.51 Mn |
| Dec 31, 2023 | 21.51 Mn |
| Sep 30, 2023 | 21.74 Mn |
| Jun 30, 2023 | 17.92 Mn |
| Mar 31, 2023 | 29.41 Mn |
| Dec 31, 2022 | 23.31 Mn |
| Sep 30, 2022 | 20.72 Mn |
| Jun 30, 2022 | 23.78 Mn |
| Mar 31, 2022 | 50.82 Mn |
| Dec 31, 2021 | 16.30 Mn |
API Access
Krystal Biotech Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=KRYS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "KRYS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=KRYS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();